Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG repeat expansion in the HTT gene. Although the mutant huntingtin protein is expressed from conception, clinical symptoms typically emerge in mid-adulthood. Imaging and molecular studies have raised the possibility that HD may...
Mattia Battistella, G. Damaggio, Paola Conforti et al.· Brain : a journal of neurolo...· 0 citations
It is shown that increasing cholesterol availability prevents synapse loss and restores cortico-striatal connectivity in HD models, establishing cholesterol as a critical regulator of cortico-striatal synaptic integrity in HD and supporting targeting cholesterol homeostasis as a therapeutic strategy to restore synaptic...
Allegra Lenci, Michela Villa, Andrea Scolz et al.· Pharmacological Research· 0 citations
It is shown that the proline‑rich domain regulates HTT1a transcript production via mRNA structure and SRSF7 binding, revealing sequence context-dependent control of toxic HTT generation.
Camilla Maffezzini, R. Iennaco, Andrea Scolz et al.· Nature Communications· 0 citations
These findings highlight the PRD’s contribution to HD toxicity and point to MKL2/MRTFB and the cytoskeleton and transcriptional coactivator MKL2/MRTFB and the cytoskeleton as candidate mediators.
R. Iennaco, Camilla Maffezzini, Simone Maestri et al.· bioRxiv· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.